Kirkland’s Healthcare & Life Sciences Regulatory Practice Group has extensive experience in advising clients on a diverse array of critical matters, including federal and multi-state considerations, precise structuring and pivotal statutes like the Federal Anti-Kickback Statute, state anti-kickback laws, and the Federal False Claims Act. The team regularly provides counsel on intricate regulatory concerns related to Medicare, Medicaid, fraud and abuse and HIPAA, and has noteworthy experience in federal and state licensure, the corporate practice doctrine (medicine, dentistry, etc.), physician practices, hospital facility compliance, provider enrollment and reimbursement matters. Additionally, our attorneys guide clients through the complex landscape of healthcare IT, healthcare-related privacy, data security, breach notification and interoperability laws.
The Healthcare & Life Sciences Regulatory group adeptly handles everyday regulatory considerations that significantly affect healthcare and life sciences companies and vendors, including pharmaceutical and medical device manufacturing, clinical research, sales, marketing, compliance and market exclusivity concerns. Drawing from extensive experience in both buy- and sell-side transactions, our team possesses the capacity to scrutinize regulatory matters from dual perspectives, effectively streamlining the transaction process.
Learn more about Healthcare & Life Sciences Transactions.
100+ Healthcare & Life Sciences Transactions
Recognized in both "Healthcare: Life Sciences" and "Healthcare: Service Providers"
The Legal 500 United States, 2022
Law Firm of the Year in Healthcare Services
The Deal, 2022